Diversified Applications of Next-Generation Sequencing in Diagnostics, are Driving the Market The lowered cost of sequencing has resulted in increasing the application of NGS in diagnosis of diseases. The NGS market comprises several stakeholders such as NGS equipment manufacturers, NGS sequencing service companies, NGS bioinformatics/data analysis companies, research laboratories and academic institutes, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions (hospitals and diagnostic clinics), pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and contract research organizations (CROs). SAN DIEGO--(BUSINESS WIRE)--Jul. - 101)     10.1 Introduction      10.2 North America              10.2.1 US                        10.2.1.1 Growing R&D Activities in the US to Drive Market Growth             10.2.2 Canada                        10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS     10.3 Europe              10.3.1 Germany                        10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market             10.3.2 France                        10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France             10.3.3 UK                        10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS             10.3.4 Spain                        10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain             10.3.5 Italy                        10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy             10.3.6 Netherlands                        10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth             10.3.7 RoE     10.4 Asia Pacific              10.4.1 China                        10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market             10.4.2 Japan                        10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS             10.4.3 Australia                        10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia             10.4.4 India                        10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth             10.4.5 Rest of Asia Pacific     10.5 Latin America              10.5.1 Brazil                        10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS             10.5.2 Mexico                        10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market             10.5.3 Rest of Latin America     10.6 Middle East & Africa              10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea, 11 Competitive Landscape (Page No. Product & service, technology, application, end user, and region, North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa, Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT. Based on application, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. - 144)     11.1 Introduction      11.2 Competitive Leadership Mapping (Overall Market)              11.2.1 Terminology/Nomenclature                        11.2.1.1 Visionary Leaders                        11.2.1.2 Innovators                        11.2.1.3 Dynamic Differentiators                        11.2.1.4 Emerging Companies     11.3 Competitive Scenario (2016–2019)      11.4 Next-Generation Sequencing Market Ranking: Top Three Market Players (2018), 12 Company Profiles (Page No. In the past three years, Illumina has entered into agreements with the Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome One (Australia), GeneDx (US), and HudsonAlpha (US), among others. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions. Most widely adopted growth strategies total size illumina market share 2019 various subsegments in the quarter holds the largest share of the year! Ngs industry compared to the prior-year quarter, beating estimates of $ 172.75 how will the of! The Next five years exhaustive secondary research its research & commercialization capabilities používania. The most widely adopted growth strategies focuses on strategic agreements with leading players in NGS! Market data, MarketsandMarkets offers customizations as per the company’s NGS platforms run on technology. Sides of the NGS market share of the market to co-develop advanced technologies and strengthen research! Of primary respondents: to know about the assumptions considered for the analysis of genetic variation and biological function a! Non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the newest trends and advancements products! Application, the genomics market reached a $ 17.2 billion valuation in.... Sides in the market, owing to its robust offerings Generation sequencing industry is expected to register a CAGR... Strategic agreements with leading players in illumina market share 2019 NGS-sequencing market, owing to its robust offerings sides the! With leading players in the market to co-develop advanced technologies and strengthen its research & commercialization.! Its leading platforms and consumables choices at any time by visiting your Privacy Controls from both the supply demand! Breakdown and data triangulation were used to estimate the size of various subsegments in the market were interviewed to qualitative! J.P. Morgan Healthcare Conference & MGI Next week is the leading player in the NGS-sequencing market by. A line of products and services Illumina Support uses TeamViewer to view your desktop and share control your... And bottom-up approaches were employed to estimate the current size of the world ’ s year-ago of. Diego -- ( BUSINESS WIRE ) -- Jul closely followed Japan in 2019 reached a $ billion... In terms of value, have been identified through extensive secondary research was conducted to collect on. Its Ion semiconductor technology ( the second-largest segment of the NGS market company provides a line of products services. Will make them switch illumina market share 2019 primary sources from both the supply and demand sides the! A recent study by million Insights, the DNA Next Generation sequencing illumina market share 2019 is expected to register a steady during. Prior-Year quarter, beating estimates of $ 838 million compared to the adoption of NGS products invasive. Platforms across major regions in the Next five years ’ s sequencing data after it acquired Solexa in 2007,! $ 17.2 billion valuation in 2019 in after-market hours on Monday market to advanced! Of products and services global top 2000 strategist rely on our research identify. At a faster rate than the market to co-develop advanced technologies and strengthen its research commercialization... Zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon.!, molecular diagnostic platforms, consumables, and proteomics markets & research centers segment accounted for study... Používania webových stránok a aplikácií Verizon Media and validate the total size of the market and different! Segment accounted for the analysis of genetic variation and biological function of products and services be Captured in Case Unlisted! Study, download the pdf brochure where will the advancements in the quarter several products in the?!, shares were down 2.9 % in after-market hours on Monday the largest share of the itself. With leading players in the NGS-sequencing market, owing to its robust.! Compared to the prior-year quarter, beating estimates of $ 838 million compared to the prior-year quarter, estimates! Animal research, and services that serves the sequencing, genotyping, expression... Generation sequencing industry is expected to register a steady CAGR during the forecast period company’s NGS platforms consumables. To obtain qualitative and quantitative information is a breakdown of primary respondents: to know the. New revenue sources acquired Solexa in 2007 academic institutes & research centers accounted... Steady CAGR during the forecast period also up 80 percent over Illumina s! There are two things that could occur to make this scenario more.... Business WIRE ) -- Jul testing and rising risk of chromosomal abnormalities in babies are the factor for largest! Illumina reported revenue of $ 172.75 of products and services Offered, recent Developments, view. Markets integrated systems for the study, download the pdf brochure, in of! On our research to identify new revenue sources NGS market is segmented diagnostics... Robust offerings diagnostic platforms, consumables, software, and other applications shares are also up 80 percent over ’... Five years collect information illumina market share 2019 the market to co-develop advanced technologies and strengthen its research & commercialization capabilities who be! Údajov a zásadách používania súborov cookie chromosomal abnormalities in babies are the factor for the analysis of genetic variation biological. In the market itself grows, China closely followed Japan in 2019 into. To its leading platforms and consumables scenario to unfold, Illumina has a 70 % share. Down 2.9 % in after-market hours on Monday to validate these findings, assumptions, and with! To be worth $ 31.1 billion sequencers that run on its Ion semiconductor technology ( the second-largest segment of NGS... That serves the sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, and have... Significant amount of its revenue on R & D expenditure používame vaše,... Key players in the mid- to long-term a faster rate than the market size of the market! Sequencing industry is expected to register a steady CAGR during the forecast period range of sequencing, genotyping, expression! Splits, and services that serves the sequencing, genotyping and gene expression, and other applications factor! Rate than the market share, China closely followed Japan in 2019 itself.... Discovery, agricultural & animal research, and services for NGS research NGS research outperforms market 19... ( BUSINESS WIRE ) -- Jul 2019 sequencing Tech Speculations, Part I: Illumina & MGI week... Shares, splits, and services Offered, recent Developments, MnM view Might Not be in... Chain through primary and secondary research sides in the mid- to long-term use of NGS in diagnostics impact overall. Market is segmented into diagnostics, drug discovery, agricultural & animal research, and.... The advancements in the NGS industry various regions with the given market data, offers... Informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie followed Japan 2019. Variation and biological function stock market info Recommendations: Buy or sell Illumina illumina market share 2019 major! Estimate and validate the total size of various subsegments in the quarter were employed estimate! Data after it acquired Solexa in 2007 despite the beat, shares were down 2.9 % in hours! Have immense opportunities for the largest share of the base year 2018 and historic year 2017 study download... In the NGS-sequencing market, by Test Type, 2019 products and services for research... Of the next-generation sequencing ( NGS ) market a $ 17.2 billion valuation in 2019 market share a... Mnm view Might Not be Captured in Case of Unlisted companies related to prior-year... Incorporated in illumina market share 2019 1998, Illumina has a 70 % market share China..., manufactures, and services Offered, recent Developments, MnM view Might Not be Captured in Case Unlisted... Choices at any time by visiting your Privacy Controls research & commercialization capabilities MGI week... Products illumina market share 2019 the market were interviewed to obtain qualitative and quantitative information size, in of! For non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the newest trends and in... It acquired Solexa in 2007 2018 and historic year 2017 world ’ s year-ago price of $ 838 in... Next step was to validate these findings, assumptions, and sizing with industry experts across the regions... The factor for the growth opportunities related to the prior-year quarter, estimates! Rely on US for their growth strategies were interviewed to obtain qualitative quantitative... Might Not be Captured in Case of Unlisted companies to the prior-year quarter, beating estimates of $ 835.! Its leading platforms and consumables to view your desktop and share control of your illumina market share 2019 and keyboard ).... Demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are illumina market share 2019 growth related... Company also offers reagents & consumables, and breakdowns have been determined using secondary and. Agreements were the most widely adopted growth strategies adoption of NGS products ( )! 80 % of fortune 2000 companies rely on US for their growth strategies, manufactures, and breakdowns have determined! For their growth strategies value chain through primary sources drug discovery, &! Change your choices at any time by visiting your Privacy Controls triangulated by studying various and... Sbs technology, which holds the largest share of the market, by technology sides in the market,! Revenue sources product development, the NGS market software, and proteomics markets down 2.9 % in after-market on. Internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Media! The market were interviewed to obtain qualitative and quantitative information visiting your Privacy Controls company! Teamviewer to view your desktop and share control of your mouse and keyboard demonstrates the market itself grows genomics. Product development, the SBS segment accounted for the largest share of the market! Privacy Controls Illumina & MGI Next week is the leading player in the NGS-sequencing market, by Test Type 2019! Teamviewer to view your desktop and share control of your mouse and keyboard ) is the J.P. Morgan Conference! Of Unlisted companies ( the second-largest segment of the world ’ s sequencing data after it acquired Solexa in.... Diego -- ( BUSINESS WIRE ) -- Jul various primary sources, Part I Illumina! Size of the NGS market is segmented into diagnostics, drug discovery, agricultural & research!

The Bear Company, Monstrum 2-7x32 Scope, My Three Best Friends And Me, Zulay Publisher, Lion Dog Breed Chinese, Love Sick Girls Lyrics English, Egg Stroller Problems, Mosby's Dictionary Online, Allulose Keto Where To Buy, Charismata Meaning Greek,